Deep Track Capital, LP

Filing Details

13F-HR • 2025-03-31

SEC FilingSEC DataHachi Filing

Report Date: 2025-03-31
Filing Date: 2025-05-15
Total Holdings: 69
Total Value: 3088173822
Accession Number: 0001856083-25-000002
Form Type: 13F-HR
CIK: 0001856083
Manager Name: Deep Track Capital, LP

Data Enrichment

93% identified

64 identified5 unidentified

Holdings

SEC FilingSEC DataHachi Filing

Manager:

69 positions • $3,088,173.822K total value

69 positions

Manager:

SEC FilingSEC DataHachi Filing

Search and click to pin securities to the top

Page 2 of 4

Sort by:

Dianthus Therapeutics, Inc. /DE/

DNTH|252828108

2357702

Value:

$42.8B

Immunocore Holdings plc

IMCR|45258D105

1411402(+171.7%)

Value:

$41.9B(+173.3%)

Celldex Therapeutics, Inc.

CLDX|15117B202

2000000(+29.9%)

Value:

$36.3B(-6.7%)

578784100

3269126

Value:

$36.0B

AMGEN INC

AMGN|031162100

113035

Value:

$35.2B

Xenon Pharmaceuticals Inc.

XENE|98420N105

1000000(+491.3%)

Value:

$33.5B(+406.0%)

Edgewise Therapeutics, Inc.

EWTX|28036F105

1400000(+97.1%)

Value:

$30.8B(+62.4%)

59267L107

1094408

Value:

$29.8B

Vaxcyte, Inc.

PCVX|92243G108

750000

Value:

$28.3B

Autolus Therapeutics plc

AUTL|05280R100

17849482(+25.5%)

Value:

$27.7B(-17.2%)

Bicara Therapeutics Inc.

BCAX|055477103

2000000(+0.0%)

Value:

$26.1B(-25.2%)

COMPASS Pathways plc

CMPS|20451W101

8859648

Value:

$25.3B

Tectonic Therapeutic, Inc.

TECX|878972108

1401938

Value:

$24.8B

Abivax S.A.

ABVX|00370M103

3579209(+0.0%)

Value:

$22.4B(-14.6%)

MBX Biosciences, Inc.

MBX|55287L101

3018935(+0.0%)

Value:

$22.3B(-60.0%)

GH Research PLC

GHRS|G3855L106

2000000

Value:

$22.1B

Dyne Therapeutics, Inc.

DYN|26818M108

2000000(+0.0%)

Value:

$20.9B(-55.6%)

29286M105

4557575(+0.0%)

Value:

$20.4B(-32.6%)

INSMED Inc

INSM|457669307

254751

Value:

$19.4B

GALAPAGOS NV

GLPG|36315X101

741068(-5.1%)

Value:

$18.6B(-13.3%)

Instrument	Shares		Other Manager	Value
Dianthus Therapeutics, Inc. /De/(DNTHcusip252828108)	2.4M	QoQ NEW(+2.4M) YoY NEW(+2.4M)	All Managers (Combined)	$42.8M	QoQ NEW(+$42.8M) YoY NEW(+$42.8M)
Immunocore Holdings Plc(IMCRcusip45258D105)	1.4M	QoQ +171.74% (+892.0K) YoY NEW(+1.4M)	All Managers (Combined)	$41.9M	QoQ +173.31% (+$26.6M) YoY NEW(+$41.9M)
Celldex Therapeutics, Inc.(CLDXcusip15117B202)	2.0M	QoQ +29.85% (-459.9K) YoY NEW(+2.0M)	All Managers (Combined)	$36.3M	QoQ -6.72% (-$2.6M) YoY NEW(+$36.3M)
(cusip578784100)✕	3.3M	QoQ NEW(+3.3M) YoY NEW(+3.3M)	All Managers (Combined)	$36.0M	QoQ NEW(+$36.0M) YoY NEW(+$36.0M)
Amgen Inc(AMGNcusip031162100)	113.0K	QoQ NEW(+113.0K) YoY -79.44% (-437.0K)	All Managers (Combined)	$35.2M	QoQ NEW(+$35.2M) YoY -77.47% (-$121.2M)
Xenon Pharmaceuticals Inc.(XENEcusip98420N105)	1.0M	QoQ +491.25% (+830.9K) YoY NEW(+1.0M)	All Managers (Combined)	$33.5M	QoQ +406.03% (+$26.9M) YoY NEW(+$33.5M)
Edgewise Therapeutics, Inc.(EWTXcusip28036F105)	1.4M	QoQ +97.06% (+689.6K) YoY NEW(+1.4M)	All Managers (Combined)	$30.8M	QoQ +62.37% (+$11.8M) YoY NEW(+$30.8M)
(cusip59267L107)✕	1.1M	QoQ NEW(+1.1M) YoY NEW(+1.1M)	All Managers (Combined)	$29.8M	QoQ NEW(+$29.8M) YoY NEW(+$29.8M)
Vaxcyte, Inc.(PCVXcusip92243G108)	750.0K	QoQ NEW(+750.0K) YoY NEW(+750.0K)	All Managers (Combined)	$28.3M	QoQ NEW(+$28.3M) YoY NEW(+$28.3M)
Autolus Therapeutics Plc(AUTLcusip05280R100)	17.8M	QoQ +25.53% (-3.6M) YoY +16.87% (-2.6M)	All Managers (Combined)	$27.7M	QoQ -17.20% (-$5.7M) YoY -71.60% (-$69.8M)
Bicara Therapeutics Inc.(BCAXcusip055477103)	2.0M	QoQ 0.00% (-0) YoY NEW(+2.0M)	All Managers (Combined)	$26.1M	QoQ -25.20% (-$8.8M) YoY NEW(+$26.1M)
Compass Pathways Plc(CMPScusip20451W101)	8.9M	QoQ NEW(+8.9M) YoY NEW(+8.9M)	All Managers (Combined)	$25.3M	QoQ NEW(+$25.3M) YoY NEW(+$25.3M)
Tectonic Therapeutic, Inc.(TECXcusip878972108)	1.4M	QoQ NEW(+1.4M) YoY NEW(+1.4M)	All Managers (Combined)	$24.8M	QoQ NEW(+$24.8M) YoY NEW(+$24.8M)
Abivax S.A.(ABVXcusip00370M103)	3.6M	QoQ 0.00% (-0) YoY -16.71% (-718.2K)	All Managers (Combined)	$22.4M	QoQ -14.61% (-$3.8M) YoY -63.59% (-$39.1M)
Mbx Biosciences, Inc.(MBXcusip55287L101)	3.0M	QoQ 0.00% (-0) YoY NEW(+3.0M)	All Managers (Combined)	$22.3M	QoQ -59.95% (-$33.4M) YoY NEW(+$22.3M)
Gh Research Plc(GHRScusipG3855L106)	2.0M	QoQ NEW(+2.0M) YoY NEW(+2.0M)	All Managers (Combined)	$22.1M	QoQ NEW(+$22.1M) YoY NEW(+$22.1M)
Dyne Therapeutics, Inc.(DYNcusip26818M108)	2.0M	QoQ 0.00% (-0) YoY -56.09% (-2.6M)	All Managers (Combined)	$20.9M	QoQ -55.60% (-$26.2M) YoY -83.82% (-$108.4M)
(cusip29286M105)✕	4.6M	QoQ 0.00% (-0) YoY +102.55% (-2.3M)	All Managers (Combined)	$20.4M	QoQ -32.63% (-$9.9M) YoY -46.46% (-$17.7M)
Insmed Inc(INSMcusip457669307)	254.8K	QoQ NEW(+254.8K) YoY -94.67% (-4.5M)	All Managers (Combined)	$19.4M	QoQ NEW(+$19.4M) YoY -85.02% (-$110.3M)
Galapagos Nv(GLPGcusip36315X101)	741.1K	QoQ -5.08% (-39.7K) YoY NEW(+741.1K)	All Managers (Combined)	$18.6M	QoQ -13.30% (-$2.9M) YoY NEW(+$18.6M)